Sign in
4

Changes in Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0001584759-26-000017

Director sold 6,700 shares at $12.91 ($86,524)

  • Director acquired 3,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Heyman Richard A. Director 2026-10-01 Option exercise 10b5-1 +3,500 $1.60 $5,600 41,800 D: show line 1 in the form
Heyman Richard A. Director 2026-10-01 Sale 10b5-1 −3,500 $12.91 $45,199 38,300 D: show line 2 in the form
Heyman Richard A. Director 2026-10-01 Sale 10b5-1 −3,200 $12.91 $41,325 203,472 I: show line 3 in the form
Open-market sales · 6,700 sh · avg $12.91 · $86,524

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Heyman Richard A. Director 2026-10-01 Option exercise · Stock Option (right to buy) 10b5-1 −3,500 26,700 D: show line 4 in the form
Loading xslF345X06/form4-10022026_091044.xml…